Healthcare -
Biotechnology - NASDAQ - US
$ 8.02
-0.125 %
$ 178 M
Market Cap
-3.68
P/E
INMB - LONG-TERM DEBT
Long-term Debt INMB - INmune Bio, Inc.
397 K
LAST VALUE
-83.82%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR